about
Macrocyclic histone deacetylase inhibitorsDevelopment of Novel Erythromycin Derivatives with Inhibitory Activity against Proliferation of Tumor CellsBifunctional Conjugates with Potent Inhibitory Activity Towards Cyclooxygenase and Histone DeacetylaseAntimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeleton.3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition.Histone deacetylase inhibitors equipped with estrogen receptor modulation activity.Macrolide-peptide conjugates as probes of the path of travel of the nascent peptides through the ribosome.Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cellsA structure-activity relationship study of the antimalarial and antileishmanial activities of nonpeptide macrocyclic histone deacetylase inhibitorsDiscovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase InhibitorsStructure, mechanism, and inhibition of histone deacetylases and related metalloenzymes.Exploiting translational stalling peptides in an effort to extend azithromycin interaction within the prokaryotic ribosome nascent peptide exit tunnel.New patented histone deacetylase inhibitors.Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed.Current trends in the development of histone deacetylase inhibitors: a review of recent patent applications.Macrocycles as potential therapeutic agents in neglected diseases.Design, synthesis and evaluation of antiproliferative activity of melanoma-targeted histone deacetylase inhibitors.A structure-activity relationship of non-peptide macrocyclic histone deacetylase inhibitors and their anti-proliferative and anti-inflammatory activities.Natural and Synthetic Macrocyclic Inhibitors of the Histone Deacetylase Enzymes.Selective histone deacetylase small molecule inhibitors: recent progress and perspectives.Dual-acting histone deacetylase-topoisomerase I inhibitors.Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors.Design and synthesis of novel histone deacetylase inhibitor derived from nuclear localization signal peptide.Molecular architecture of zinc chelating small molecules that inhibit spliceosome assembly at an early stage.The design and synthesis of a new class of RTK/HDAC dual-targeted inhibitors.Structure-activity relationships of hydroxamate-based histone deacetylase-8 inhibitors: reality behind anticancer drug discovery.
P2860
Q24629065-62D887EF-9BEC-4212-94CE-00781301A009Q28552828-62A26E03-C8B5-4D39-8B89-588BC5137EA2Q29248227-9CFE38AE-A95F-4E5E-8407-EEB6FA41866AQ33637372-3BA30215-5778-4A2B-A500-A1C4BB5082CBQ34075642-43A36883-9FBE-44EF-81D1-E10FA44EB23BQ34336500-AAF1C9CB-FCAE-4C3D-B740-1F70A8BF3BEAQ34352264-97D0DA08-CC8D-404F-98A8-98EE780E8BDBQ34576226-78108919-DFC7-4EDC-A64F-F80009232F8DQ35096555-14D97485-1A75-4B5D-A6B9-F0505590BF91Q35110645-332A1031-9D4E-42FA-BB28-397A570433DBQ35178901-F88EA756-C6D4-4F73-95C6-BD5A065405DAQ35597103-053F5662-7472-40B9-9AA5-D5003B4BB77AQ35952044-C9978B24-B081-40A0-AEF1-8115FD6AAC1DQ37638742-502722BD-60E8-47D6-AB81-98424FF101C7Q37993589-CA1376B4-E83E-44FF-9EAB-605D4E90C588Q38162900-F7C13031-D93B-4DA9-BC28-16D1BE84ADECQ38343825-A7962588-B485-4330-8585-9A932330828AQ38718989-D84B276F-FC40-4050-AB5C-0BE28D84F18FQ38818334-FCE8468A-B7CE-4328-8477-F2EB3CB23F45Q38982458-756C4CBF-31C8-4F81-9454-23AC30CC97FCQ39062353-F6D3323F-598D-4D9D-8E5E-1E35EF7DC21BQ39159726-28562570-866D-4FA2-8CCF-0A3E52931897Q39409844-F7B9CC36-0C7E-46FB-BD50-A9DAA6B98247Q41957873-7763258B-CE4C-4546-8636-F3C0C0C7CF34Q42288523-6CED4608-1637-4F4D-921F-C6B191F1D100Q45335806-5716297B-6EF9-4A22-9F20-42FFF4603266Q47357144-A6663443-4161-4C20-8FDC-EC85D0876ADA
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Non-peptide macrocyclic histone deacetylase inhibitors.
@en
Non-peptide macrocyclic histone deacetylase inhibitors.
@nl
type
label
Non-peptide macrocyclic histone deacetylase inhibitors.
@en
Non-peptide macrocyclic histone deacetylase inhibitors.
@nl
prefLabel
Non-peptide macrocyclic histone deacetylase inhibitors.
@en
Non-peptide macrocyclic histone deacetylase inhibitors.
@nl
P2093
P2860
P356
P1476
Non-peptide macrocyclic histone deacetylase inhibitors.
@en
P2093
Adegboyega K Oyelere
Sandra C Mwakwari
William Guerrant
Yuhong Fan
Yunzhe Zhang
P2860
P304
P356
10.1021/JM801128G
P407
P50
P577
2009-01-01T00:00:00Z